alexa Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virus.
Infectious Diseases

Infectious Diseases

Journal of AIDS & Clinical Research

Author(s): Sculley TB, Cross SM, Borrow P, Cooper DA, Sculley TB, Cross SM, Borrow P, Cooper DA

Abstract Share this page

Abstract We measured the presence of antibodies to the Epstein-Barr virus (EBV) nuclear antigen 2B (EBNA2B) in patients with AIDS and related disorders, persons with human immunodeficiency virus (HIV) infection, persons at risk for HIV infection, and normal persons. Sera from 38\% (16 of 43) of the patients with AIDS and 35\% (43 of 123) of HIV-positive individuals reacted with EBNA2B, versus 25\% (21 of 83) of the high-risk patients and 7.5\% (5 of 65) of the normal persons. Screening these sera against cell lines that express EBNA2B, EBNA2A, or neither antigen revealed that only a proportion of these sera contained EBNA2B-specific antibodies. Many sera reacted with both antigens. Of the EBNA2B-specific sera, 14\% (6 of 43) were from patients with AIDS, 16\% (20 of 123) from HIV-positive individuals, 5\% (4 of 83) from high-risk individuals, and 4.5\% (3 of 65) from normal persons. The presence of antibodies to the EBNA2B in HIV-infected individuals indicates that they may be infected with type B strains of EBV.
This article was published in J Infect Dis and referenced in Journal of AIDS & Clinical Research

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords